Allergan Textured Breast Implants Lawsuit

Allergan Breast Implants Lawsuit

Levin Sedran & Berman LLP is investigating potential cases relating to the recalled Allergan textured breast implant models detailed below. If you have received one of the recalled implants and have experienced any of the symptoms below, please contact our firm for a free case evaluation.

IMPORTANT: The information provided on this website is not a substitute for professional medical advice. If you are currently experiencing any side effect from Allergan breast implants, contact a healthcare professional immediately.


Worldwide Recall

Allergan TEXTURED surface implants were recalled worldwide on July 24, 2019.

The FDA revealed over 500 women worldwide who received textured breast implants were diagnosed with a rare form of non-Hodgkin’s lymphoma cancer known as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). 33 of those breast implant cancer cases resulted in patients’ deaths.

The FDA linked Allergan, Inc., manufacturers of textured breast implants, to nearly 84% of those breast implant cancer cases. Allergan’s BIOCELL textured breast implants and tissue expanders have all been recalled: check with your health care professional today to see if you received an Allergan textured breast implant.

Symptoms of BIA-ALCL
Breast Lump or Lumps
Fluid Build-up
Hardening of or Mass Around Breast Implant
Persistent Swelling Near Breast Implant
Persistent Pain Near Breast Implant


BREAST IMPLANT CANCER DETECTION
How is BIA-ALCL diagnosed? Once patients have symptoms such as those listed above, doctors collect fluid samples for testing. Positive results include the presence of malignant T-cells.

Doctors may also use a number of different tests to diagnose non-Hodgkin’s lymphoma, such as:
Physical exams
Biopsies
Chest X-rays
Computed tomography (CT) scans
Magnetic resonance imaging (MRI) scans
Ultrasound imaging tests
Positron emission tomography

CURRENTLY THE FDA DOES NOT RECOMMEND THAT THOSE FREE OF BIA-ALCL SYMPTOMS HAVE THEIR IMPLANTS REMOVED. THE FDA HAS URGED THOSE WITH TEXTURED IMPLANTS TO MONITOR ANY CHANGES AND REPORT THEM TO THEIR HEALTHCARE PROVIDER. CANCER FROM TEXTURED IMPLANTS CAN TAKE YEARS TO DEVELOP, SO THE FDA SUGGESTS CLOSE AND REGULAR MONITORING FOR SYMPTOMS

RECALL IMPACTS
Allergan Natrelle Saline-Filled Breast Implants (previously sold as the McGhan RTV Saline-Filled Mammary Implant) in styles 163, 168, 363 and 468.
Allergan Natrelle Silicone-Filled Textured Breast Implants (previously known as Inamed Silicone-Filled Breast Implants) in styles 110, 115, 120, TRL, TRLP, TRM, TRF, TRX, TCL, TCLP, TCM, TCF, TCX, TSL, TSLP, TSM, TSF, and TSX.
Natrelle 410 Highly Cohesive Anatomically Shaped Silicone Filled Breast Implants in styles 410FM, 410FF, 410MM, 410 MF, 410 ML, 410 LL, 410 LM, 410 LF, 410 FX, 410 MX, and 410 LX.
Natrelle 133 Plus Tissue Expander
Natrelle 133 Tissue Expander with Suture Tabs
Further information regarding the recall can be found here:

CONTACT US TODAY

As an experienced, professional team, Levin, Sedran & Berman LLP provide superior representation in all cases.